Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Mol Cancer Ther. 2015 Apr 3;14(6):1376–1384. doi: 10.1158/1535-7163.MCT-15-0036

Figure 3. CD30 staining in tissue from ALCL patients resistant to BV.

Figure 3

Please see methods section on CD30 immunohistochemical staining. Biopsy post BV was done at the time of disease relapse while off BV or disease progression while on BV. CD 30 expression is retained in both scenarios.